Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

48.94
Delayed Data
As of Apr 29
 +0.21 / +0.43%
Today’s Change
29.00
Today|||52-Week Range
51.59
+9.56%
Year-to-Date

Today’s Trading

Previous close48.73
Today’s open47.96
Day’s range47.29 - 49.24
Volume340,455
Average volume (3 months)264,670
Market cap$1.1B
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)-50.35%
Earnings growth (this year)+19.14%
Earnings growth (next 5 years)+19.30%
Revenue growth (last year)+16.11%
P/E ratio70.2
Price/Sales2.98
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc-0.16-0.53%
CNMDConmed Corp-0.97-2.29%
PTLAPortola Pharmaceutic...-0.80-3.26%
MDXGMiMedx Group Inc-0.27-3.46%
Data as of 04/29/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.34
Annual revenue (last year)$339.5M
Annual profit (last year)$15.8M
Net profit margin4.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael R. Davin
President, Chief Financial &
Operating Officer
Timothy W. Baker
Corporate headquarters
Westford, Massachusetts

Forecasts

Partner Offers

Search for Jobs